FDA approves OraSure's hepatitis C test

06/27/2010 | Reuters

OraSure Technologies announced that it secured FDA approval for OraQuick, a test that can spot antibodies to the hepatitis C virus using a patient's blood sample. An analyst for Needham & Co. said the FDA could approve an oral fluid test version of the company's OraQuick this year.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ